VEGFR-3 / Flt-4 (His-tag) Human Protein
CAT#: DA3535X
VEGFR-3 / Flt-4 (His-tag) human recombinant protein, 50 µg
Need it in bulk or customized? Get a free quote |
CNY 6,680.00
货期*
7周
规格
Product images
Specifications
Product Data | |
Species | Human |
Expression Host | Insect |
Tag | His-tag |
Predicted MW | 120 kDa |
Purity | >90% by SDS-PAGE and visualised by silver stain |
Buffer | Presentation State: Purified State: Lyophilized without buffer and stabilizer. |
Preparation | Lyophilized without buffer and stabilizer. |
Protein Description | The recombinant mature sVEGFR-3/FLT-4 is a glycosylated monomeric protein with a mass of approximately 120 kDa. The soluble receptor protein consists of all 7 extracellular domains (Met1-Glu774). |
Note | Centrifuge vials before opening! |
Storage | Prior to and following reconstitution store the antibody at -20°C. Avoid repeated freezing and thawing. |
Stability | Shelf life: one year from despatch. |
Bioactivity | Biological: Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human sVEGFR-3/FLT-4 at 5 µg/ml can bind recombinant rat VEGF-C in a linear range of 8-500 ng/ml. |
Endotoxin | < 0.1 ng per µg of sVEGFR-3 |
Reference Data | |
RefSeq | NP_001341918 |
Locus ID | 2324 |
Cytogenetics | 5q35.3 |
Synonyms | VEGFR3, FLT4, VEGF Receptor 3 |
Summary | This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008] |
Protein Families | Druggable Genome, Protein Kinase, Transmembrane |
Protein Pathways | Cytokine-cytokine receptor interaction, Focal adhesion |
Documents
FAQs |
SDS |
Customer
Reviews
Loading...